ICON Acquires MeDiNova Research in Europe and Africa

May 24, 2019

Applied Clinical Trials

ICON plc has announced that it has acquired a majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, and that it has the right to acquire the remaining shares in the company by Quarter Three 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.

For more information click here.

Related Content:

News